Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Xarelto (rivaroxaban) and Savaysa (edoxaban) are both blood thinners used to prevent blood clots and strokes, but they have some differences. Xarelto is a direct-acting oral anticoagulant (DOAC) that works by stopping factor Xa, a protein involved in blood clotting. It’s used for a variety of conditions, including atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). It can be taken once or twice a day depending on the condition being treated. Savaysa also stops factor Xa but is typically taken once a day and is mainly used for nonvalvular atrial fibrillation (NVAF) and major blood clots. Unlike Xarelto, Savaysa doesn’t have an antidote for serious bleeding, making it potentially riskier in emergencies. Both are only available as brand-name medications. Neither require frequent blood tests like warfarin, but Xarelto can be used in very young children, whereas Savaysa is not indicated for pediatric use.
Xarelto (rivaroxaban)
Savaysa (edoxaban)
Xarelto (rivaroxaban)
Savaysa (edoxaban)
Summary of Xarelto vs. Savaysa
Summary for Direct-acting oral anticoagulant (DOAC)
Prescription only
Xarelto (rivaroxaban) is a prescription blood thinner used to prevent and treat blood clots. It can lower the risk of serious problems like stroke, deep vein thrombosis (DVT), or pulmonary embolism (PE). It's comes as a tablet or liquid and is taken by mouth. Your dose depends on why you're taking it, so it could be once or twice a day. The most common side effect is bleeding, which can sometimes be serious or life-threatening. Xarelto (rivaroxaban) is available as both a brand-name and a generic medication.
Summary for Anticoagulant
Prescription only
Savaysa, the brand name for edoxaban, is an anticoagulant (blood thinner). It’s used to help prevent blood clots and strokes in certain people with atrial fibrillation. This medication can also treat blood clots. The dose is typically one 60 mg tablet by mouth once daily, but it might be lower if you have kidney problems. Since it’s a blood thinner medication, Savaysa (edoxaban) can raise your chance of bleeding as a side effect. As of early 2025, there's no FDA-approved generic version available yet.